نتایج جستجو برای: orlistat

تعداد نتایج: 785  

Journal: :The British journal of nutrition 2011
Kamilia Tai Diana Gentilcore Karen L Jones Lisa Banh Odd Helge Gilja Angela J Hammond Christine Feinle-Bisset Michael Horowitz Ian M Chapman

Postprandial hypotension may be influenced by the digestion of fat. The aim of the present study was to evaluate the hypothesis that products of fat digestion mediate the hypotensive response to fat. In part A of the study, nine healthy older subjects were studied on three separate occasions in randomised order. Blood pressure, heart rate (HR), plasma TAG and gastric emptying were measured foll...

Journal: :Diabetes care 2004
Jarl S Torgerson Jonathan Hauptman Mark N Boldrin Lars Sjöström

OBJECTIVE It is well established that the risk of developing type 2 diabetes is closely linked to the presence and duration of overweight and obesity. A reduction in the incidence of type 2 diabetes with lifestyle changes has previously been demonstrated. We hypothesized that adding a weight-reducing agent to lifestyle changes may lead to an even greater decrease in body weight, and thus the in...

2000
Michael H Davidson

In your June editorial, “Is Blockade of Pancreatic Lipase the Answer?” (1), you suggest that the success of the 2-y clinical trials of orlistat is diminished by the propensity of obese patients to regain weight. I disagree. The North American Association for the Study of Obesity (NAASO) considers a weight loss of ≥ 5% to be clinically significant (2). In each of the published clinical trials of...

Journal: :international journal of endocrinology and metabolism 0
david palacios-martinez san blas health center, primary health care, sermas- madrid health service, parla, madrid, spain; los angeles avenue, 3-d. getafe, madrid, p.o.box: 28903, spain. tel: 0034661529177, fax: 0034916051429 juan carlos garcia-alvarez local office of serranillos del valle, primary health care, sermas- madrid health service, griñón, madrid, spain nieves montero-santamaria san blas health center, primary health care, sermas- madrid health service, parla, madrid, spain olga patricia villar-ruiz service of obstetrics and gynecology, 12th october universitary hospital , sermas- madrid health service, madrid, spain antonio ruiz-garcia pinto health center, primary health care: sermas- madrid health service, pinto, madrid, spain raquel asuncion diaz-alonso san blas health center, primary health care, sermas- madrid health service, parla, madrid, spain

case report: besides the interaction with other drugs (mainly warfarin and amiodarone). orlistat´s mainly side effects are gastrointestinal disorders such as the existence of oily spotting from the rectum, abdominal pain or discomfort, fecal urgency. there are also side effects at other levels, like flu symptoms, hypoglycemia, heathache or upper respiratory infections. there are other side effe...

Journal: :Nutricion hospitalaria 2011
E García Díaz T Martín Folgueras

INTRODUCTION The prevalence of obesity, a serious public health problem, is increasing among teenagers and thus also increases cardiovascular morbidity and mortality in adulthood. OBJECTIVE To provide a systematic review of the best evidence about the effect of sibutramine and orlistat in weight loss, quality of life and its adverse effects in adolescents diagnosed with obesity. METHODS We ...

Journal: :Gut 2000
J Borovicka W Schwizer G Guttmann D Hartmann M Kosinski C Wastiel A Bischof-Delaloye M Fried

BACKGROUND AND AIMS To investigate the importance of lipase on gastric functions, we studied the effects of orlistat, a potent and specific inhibitor of lipase, on postprandial gastric acidity and gastric emptying of fat. METHODS Fourteen healthy volunteers participated in a double blind, placebo controlled, randomised study. In a two way cross over study with two test periods of five days, s...

Journal: :Nutrition Journal 2006
Sarah Napier Matthew Thomas

BACKGROUND Orlistat is an anti-obesity drug licensed in the United Kingdom for 7 years. We present a case of a patient who developed pancreatitis four days after commencing orlistat. CASE PRESENTATION A 36 year old man presented to hospital with acute severe pancreatitis four days after starting a course of Orlistat, a lipase inhibitor used in the treatment of obesity. A diagnosis of drug rel...

2012
José Manuel Tirado-Vélez Insaf Joumady Ana Sáez-Benito Irene Cózar-Castellano Germán Perdomo

Multiple myeloma is a haematological malignancy characterized by the clonal proliferation of plasma cells. It has been proposed that targeting cancer cell metabolism would provide a new selective anticancer therapeutic strategy. In this work, we tested the hypothesis that inhibition of β-oxidation and de novo fatty acid synthesis would reduce cell proliferation in human myeloma cells. We evalua...

2017
Jia Choi Kui-Jin Kim Eun-Jeong Koh Boo-Yong Lee

The incidence of obesity is rising at an alarming rate throughout the world and is becoming a major public health concern with incalculable social and economic costs. Gelidium elegans (GENS), also previously known as Gelidium amansii, has been shown to exhibit anti-obesity effects. Nevertheless, the mechanism by which GENS is able to do this remains unclear. In the present study, our results sh...

2014
Laura J. Carter Catherine D. Garman James Ryan Adam Dowle Ed Bergström Jane Thomas-Oates Alistair B. A. Boxall

Pharmaceuticals present a potential threat to soil organisms, yet our understanding of their fate and uptake in soil systems is limited. This study therefore investigated the fate and uptake of (14)C-labeled carbamazepine, diclofenac, fluoxetine, and orlistat in soil-earthworm systems. Sorption coefficients increased in the order of carbamazepine < diclofenac < fluoxetine < orlistat. Dissipatio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید